In-Vitro Toxicity Testing Market
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical subs ... Read More
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
This report contains market size and forecasts of NGS-based RNA-sequencing in Global, including the following market information:
Global NGS-based RNA-sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global NGS-based RNA-sequencing market was valued at 1885.6 million in 2021 and is projected to reach US$ 5548.5 million by 2028, at a CAGR of 16.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sequencing by Synthesis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of NGS-based RNA-sequencing include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NGS-based RNA-sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NGS-based RNA-sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global NGS-based RNA-sequencing Market Segment Percentages, by Type, 2021 (%)
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Global NGS-based RNA-sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global NGS-based RNA-sequencing Market Segment Percentages, by Application, 2021 (%)
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Global NGS-based RNA-sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global NGS-based RNA-sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NGS-based RNA-sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies NGS-based RNA-sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical subs ... Read More
Healthcare Distribution is a wholesale distributor of new and innovative products for the healthc ... Read More
Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect ... Read More
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of he ... Read More